Constantine Cannon Settles Case Alleging Kickbacks to Multi-Practice Physicians’ Group for Referrals to Wholly Owned Ambulatory Surgery Center – Whistleblower Was Former CEO
Constantine Cannon, on behalf of whistleblower Jeffery Neuberger, has settled a False Claims Act action against Mid Dakota Clinic and a related entity. Mr. Neuberger, the former CEO of the medical group, filed his case in 2017 alleging a scheme in violation of the Anti-Kickback Statute (AKS) between the medical group and its wholly owned ambulatory surgery center (ASC). At issue was a financial arrangement whereby...
Constantine Cannon Celebrates a Record-Shattering Year of Whistleblower Rewards
This has been a big year for the whistleblower clients of Constantine Cannon. Our whistleblower team represented the whistleblowers in four blockbuster settlements in just the past twelve months. In two of those cases, the government declined to pursue the matter so we had to litigate on our own.
More importantly for our clients, in all four cases Constantine Cannon secured some of the highest whistleblower...
Catch of the Week: 345 Charged in $6 Billion National Health Care Fraud and Opioid Takedown
In the largest health care fraud and opioid enforcement action in the Justice Department’s history, 345 defendants—including more than 100 doctors, nurses, and other medical professionals—face charges for submitting over $6 billion in false or fraudulent claims to federal and private insurers. Defendants stand accused of submitting $4.5 billion in fraudulent claims linked to telemedicine, $845 million...
How Whistleblowers Can Report Fraud Related to Clinical Trials
The COVID-19 pandemic has highlighted the importance of government-funded scientific and medical research, including clinical trials of vaccines, treatments, and more. We are all potentially at risk if there is fraud and abuse in clinical trials and other research.
Individuals with knowledge of fraud and misconduct in federal grants and clinical trials may be able to bring a whistleblower action for that research...
Watch: Jessica Moore Discusses Assisted Living Facility Safety on Tampa’s ABC Action News
Constantine Cannon has been following the impact of COVID-19 on nursing homes and assisted living facilities. Residents and workers at nursing homes make up a disproportionate share of U.S. coronavirus deaths, and the pandemic has imposed unique burdens on the industry.
Florida recently implemented standards that will allow visitors in to long-term care facilities, if those facilities meet specific criteria. ...
Top Takeaways from Former DOJ Civil Chief Jody Hunt on the Current State of False Claims Act Enforcement
Law360 recently interviewed former DOJ Civil Chief Jody Hunt on what he sees as the key issues surrounding False Claims Act enforcement these days. Here are the top takeaways:
COVID-relief fraud will be a DOJ priority. No surprise there given the billions of dollars the federal government is pouring into the economy to alleviate some of the financial strain the pandemic is wreaking on healthcare providers...
Windfall to Health Insurers Due to COVID-19 Is Not Yet Resulting in Resolution of FCA Risk Adjustment Cases
As health insurers book record profits during the COVID-19 pandemic due to a dramatic decline in elective surgeries and procedures, this seems like a good time to ask about the status of False Claims Act litigation against Medicare Advantage Organizations (MAOs) relating to risk adjustment fraud. Given the dire shortfall in state and federal money to fight the pandemic, when will MAOs begin paying back the billions...
New Settlement Shows the Power of Whistleblowers to Root out Fraud against Private Insurers
The nation’s biggest insurers, Medicare, Medicaid, and TRICARE already incentivize whistleblowers to report fraud. Because those programs are federally-funded, a whistleblower can bring suit under the False Claims Act and share in 15-30% of the recovery. The FCA is a law that allows private individuals alleging fraud against the government to bring a lawsuit in the name of the United States. The law leads to about...
COVID Frauds of the Week: Fraud on Stimulus Programs and Consumers
Like the virus itself, fraud that exploits the COVID-19 pandemic just will not go away, so we are back with another installment of our continuing series highlighting related government enforcement actions. This week, we saw a continued enforcement focus in two areas: fraud on stimulus programs and consumers.
Three charges this week highlighted the government’s ongoing efforts to expose and bring...
Catch of the Week: Indivior Agrees to Pay $600 Million to Settle Opioid Fraud Case
The latest in our Catch of the Week series features Indivior Solutions’ (“Indivior”) agreement to pay $600 million to resolve criminal and civil liability associated with the marketing of the opioid-addiction-treatment drug Suboxone. This is in addition to the $1.4 billion resolution with Indivior’s former parent, Reckitt Benckiser Group PLC (“RB Group”) that was previously announced in 2019. Suboxone is a...